Chronic pain is a debilitating condition that impacts tens of millions each year, resulting in lost wages for workers and exacting considerable costs in health care and rehabilitation. A thorough understanding of the neural mechanisms underlying pain and analgesia is critical to facilitate the development of therapeutic strategies and personalized medicine. Clinical and epidemiological studies report that women experience greater levels of pain than men and have higher rates of pain-related disorders. Studies in both humans and rodents report sex differences in the anatomical and physiologic properties of the descending antinociceptive circuit, mu opioid receptor (MOR) expression and binding, morphine metabolism, and immune system activation, all of which likely contribute to the observed sex differences in pain and opioid analgesia. Although more research is needed to elucidate the underlying mechanisms, these sex differences present potential therapeutic targets to optimize pain management strategies for both sexes. 
Sex differences in pain and pain sensitivity
Pain is one of the most commonly reported health problems in the United States [1, 2] . An NIH survey found that roughly 55% of American adults experienced acute pain within the previous three months, while more than 10% reported experiencing chronic pain, clinically defined as pain lasting longer than three months [3 ] . As both acute and chronic pain affect a significant portion of the population, the treatment of pain is of large-scale economic concern. Indeed, the United States' annual cost of pain treatment is estimated at $600 billion [4] .
Epidemiological studies report that women suffer from chronic pain more frequently than men [5, 6] . Women also experience higher rates of chronic pain conditions such as fibromyalgia, migraine, and osteoarthritis [2, [7] [8] [9] [10] . Although it is not clear if the increased incidence of chronic pain conditions observed in females results from greater susceptibility to such conditions or is due to women being more likely than men to report pain (for review see [11] ), women are more likely than men to use health care services for both painful and non-painful conditions [12, 13] . Women are also more likely to experience significantly higher pain levels than men with the same diagnosis [10].
Importantly, not all studies in humans report a sex difference in pain sensitivity [8] . However, when results do suggest a sex difference, women are found to be more sensitive to pain than men and experience greater adverse effects of pain than men [8, 9] .
Opioid analgesia
Opioids are the most effective and common treatment for pain management [14] , with over 65 prescriptions written per 100 Americans in 2016 [15] . Sex differences in the prescription of opioids have been reported, with women more likely than men to be prescribed opioids. Women are also prescribed higher doses than men [16, 17, 18 ]. Opioids (such as morphine and fentanyl) act by binding to neuronal mu-opioid receptors (MORs) to inhibit pain [19] . However, opioids also induce respiratory depression, gut immotility, nausea, dysphoria, headache, and vomiting, with women more likely than men to experience many of these negative side effects [20] [21] [22] [23] . Long-term opiate use also results in the development of tolerance, leading to a reduction in opioid potency that is typically countered with dose escalation [14, 24] . The development of opioid tolerance and the resulting dose increase leads to a higher risk of addiction and overdose [24] . Clinically, men are two times more likely to have used opiates, including heroin, within the past month, year, and across the lifespan ([25] ; see [26 ] for review), and preclinical studies in rodents report that males experience longer and more severe withdrawal symptoms from opiates than females [27, 28] .
The existence of sex differences in opioid analgesia remains controversial. Although some studies report no sex difference in the analgesic efficacy of opioids in humans [22, 29, 30] , other studies report that opioids exhibit decreased analgesic efficacy in women [31, 32] . Importantly, these results are dependent on the setting (clinic vs laboratory), duration of pain (acute vs chronic) and type of pain (visceral, inflammatory, or orofacial) for which opioids are prescribed. Preclinical studies using rodent models are more consistent, with the majority of
